Aleksandra Araszkiewicz

Summary

Affiliation: Medical University
Country: Poland

Publications

  1. ncbi Neurodegeneration of the retina in type 1 diabetic patients
    Aleksandra Araszkiewicz
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland
    Pol Arch Med Wewn 122:464-70. 2012
  2. ncbi Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes
    Aleksandra Araszkiewicz
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland
    Diabetes Technol Ther 13:837-42. 2011
  3. ncbi Presence of retinopathy in type 1 diabetic patients is associated with subclinical macroangiopathy
    Aleksandra Araszkiewicz
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland
    Scand J Clin Lab Invest 71:563-8. 2011
  4. ncbi The evaluation of IL-12 concentration, PAF-AH, and PLA(2) activity in patients with type 1 diabetes treated with intensive insulin therapy
    Małgorzata Wegner
    Department of General Chemistry, Chemistry and Clinical Biochemistry, Poznan University of Medical Sciences, 6 Grunwaldzka St, Poznan, Poland
    Clin Biochem 42:1621-7. 2009
  5. ncbi Carotid intima-media thickness and arterial stiffness in type 1 diabetic patients with and without microangiopathy
    Anita Rogowicz-Frontczak
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poland
    Arch Med Sci 8:484-90. 2012
  6. ncbi Assessment of skin autofluorescence as a marker of advanced glycation end product accumulation in type 1 diabetes
    Paweł Samborski
    Department of Internal Diseases, Metabolic Disorders and Dietetics, Poznan University of Medical Sciences, Poznan, Poland
    Pol Arch Med Wewn 121:67-72. 2011
  7. ncbi Evaluation of paraoxonase 1 arylesterase activity and lipid peroxide levels in patients with type 1 diabetes
    Małgorzata Wegner
    Department of General Chemistry, Chemistry and Clinical Biochemistry, Poznan University of Medical Sciences, Poznan, Poland
    Pol Arch Med Wewn 121:448-54. 2011
  8. ncbi The relationship between concentrations of magnesium and oxidized low density lipoprotein and the activity of platelet activating factor acetylhydrolase in the serum of patients with type 1 diabetes
    Małgorzata Wegner
    Department of General Chemistry, Poznan University of Medical Sciences, Poznan, Poland
    Magnes Res 23:97-104. 2010
  9. ncbi Knowledge after five-day teaching program in intensive insulin therapy performed at the onset of type 1 diabetes influence the development of late diabetic complications
    Aleksandra Araszkiewicz
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Raszeja Hospital, Mickiewicza 2, 60 834 Poznan, Poland
    Diabetes Res Clin Pract 81:61-7. 2008

Collaborators

  • Maria Piorunska-Stolzmann
  • Paweł Samborski
  • Małgorzata Wegner
  • Bogna Wierusz-Wysocka
  • Dorota Zozulińska-Ziółkiewicz
  • Anita Rogowicz-Frontczak
  • Anna Pioruńska-Mikołajczak
  • Dorota Zozulinska-Ziolkiewicz
  • Stanislaw Pilacinski
  • Andrzej Wykretowicz

Detail Information

Publications9

  1. ncbi Neurodegeneration of the retina in type 1 diabetic patients
    Aleksandra Araszkiewicz
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland
    Pol Arch Med Wewn 122:464-70. 2012
    ..Optical coherence tomography (OCT) allows to perform qualitative and quantitative measurements of retinal thickness (RT) with identification of individual retinal layers...
  2. ncbi Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes
    Aleksandra Araszkiewicz
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland
    Diabetes Technol Ther 13:837-42. 2011
    ..The aim of the study was to assess the association between AF and microvascular complications in type 1 diabetes mellitus (DM1)...
  3. ncbi Presence of retinopathy in type 1 diabetic patients is associated with subclinical macroangiopathy
    Aleksandra Araszkiewicz
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland
    Scand J Clin Lab Invest 71:563-8. 2011
    ..The aim of the study was to assess the relationships between diabetic retinopathy, subclinical atherosclerosis and wave reflection in type 1 diabetic patients...
  4. ncbi The evaluation of IL-12 concentration, PAF-AH, and PLA(2) activity in patients with type 1 diabetes treated with intensive insulin therapy
    Małgorzata Wegner
    Department of General Chemistry, Chemistry and Clinical Biochemistry, Poznan University of Medical Sciences, 6 Grunwaldzka St, Poznan, Poland
    Clin Biochem 42:1621-7. 2009
    ....
  5. ncbi Carotid intima-media thickness and arterial stiffness in type 1 diabetic patients with and without microangiopathy
    Anita Rogowicz-Frontczak
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poland
    Arch Med Sci 8:484-90. 2012
    ..The aim of the study was to assess carotid intima-media thickness (CIMT) as a subclinical marker of atherosclerosis and arterial stiffness in type 1 diabetic patients in relation to microangiopathy...
  6. ncbi Assessment of skin autofluorescence as a marker of advanced glycation end product accumulation in type 1 diabetes
    Paweł Samborski
    Department of Internal Diseases, Metabolic Disorders and Dietetics, Poznan University of Medical Sciences, Poznan, Poland
    Pol Arch Med Wewn 121:67-72. 2011
    ..Advanced glycation end products (AGEs) are important in the pathogenesis of atherosclerosis and reflect the risk of cardiovascular mortality. AGE levels are significantly higher in patients with diabetes...
  7. ncbi Evaluation of paraoxonase 1 arylesterase activity and lipid peroxide levels in patients with type 1 diabetes
    Małgorzata Wegner
    Department of General Chemistry, Chemistry and Clinical Biochemistry, Poznan University of Medical Sciences, Poznan, Poland
    Pol Arch Med Wewn 121:448-54. 2011
    ..Low paraoxonase 1 (PON1) activity and high lipid peroxide (LPO) levels contribute to endothelial damage, but it remains unclear whether they are critical for the development of late diabetic complications...
  8. ncbi The relationship between concentrations of magnesium and oxidized low density lipoprotein and the activity of platelet activating factor acetylhydrolase in the serum of patients with type 1 diabetes
    Małgorzata Wegner
    Department of General Chemistry, Poznan University of Medical Sciences, Poznan, Poland
    Magnes Res 23:97-104. 2010
    ..Therefore, the oxidative modification of LDL and the higher activity of PAF-AH are related with the low Mg status; however, no relation has been observed between these parameters and the poor metabolic control in DM1 patients...
  9. ncbi Knowledge after five-day teaching program in intensive insulin therapy performed at the onset of type 1 diabetes influence the development of late diabetic complications
    Aleksandra Araszkiewicz
    Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Raszeja Hospital, Mickiewicza 2, 60 834 Poznan, Poland
    Diabetes Res Clin Pract 81:61-7. 2008
    ..71; 95%CI: 1.15-12.01, p=0.02 for retinopathy and RR=4.33; 95%CI: 0.98-19.10, p=0.04 for microalbuminuria). The higher diabetic knowledge at baseline the better metabolic control and lower risk of microangiopathy in the future...